Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to LB-100
Related studies linked through entity extraction aliases.
LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2